Truvian Health Rapidly Expands TruVerus™ Menu with FDA Clearances for Cardiovascular, Liver, and Core Metabolic Health Tests ...

Unlike many Austrian resorts, Ischgl boasts a big variety of restaurants that are independent of hotels, although inevitably ...

Truvian Health ("Truvian"), a transformational diagnostics company redefining healthcare, today announced it has received 510(k) clearances (K251091, K251074, K251157) from the U.S. Food and Drug ...

U.S. commercial launch in thalassemia underway following December 2025 FDA approvalPre-sNDA meeting with FDA for mitapivat ...

From City Hall and state government to tech, transit and the arts, these figures are poised to shape Austin's year ahead.

Strategic collaboration expands taletrectinib global reach with a leading oncology partnerEisai will receive exclusive development, registration and commercialization rights for taletrectinib for the ...

Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced preliminary fourth quarter and full year 2025 net product revenue ...

The diagnosis and management of invasive fungal infections in adult patients with hematological malignancies remains a ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...

Researchers at the Paul Scherrer Institute PSI have achieved a breakthrough on the path to practical application of lithium ...